This company has been marked as potentially delisted and may not be actively trading. IVERIC bio (ISEE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ISEE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain InhibitorAugust 26, 2024 | venturebeat.comVAstellas Pharma Inc (ALPMY)March 10, 2024 | investing.comApellis falls on potential EU snub for eye therapy (update)December 15, 2023 | msn.comAkoya Biosciences: 2024 Could Be The Year To Own Their StockDecember 7, 2023 | seekingalpha.comApellis adds safety warning to eye therapyDecember 1, 2023 | msn.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Consensus Rating of "Hold" by AnalystsAugust 14, 2023 | marketbeat.comAmalgamated Bank Reduces Stock Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)August 7, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Consensus Rating of "Hold" by BrokeragesJuly 20, 2023 | marketbeat.comState of New Jersey Common Pension Fund D Boosts Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)July 17, 2023 | marketbeat.comAstellas Completes Acquisition of Iveric BioJuly 11, 2023 | finance.yahoo.comIVERIC bio (Nasdaq:ISEE) HeadlineTrading was temporarily halted for "ISEE" at 07:07 PM with a stated reason of "News pending."...July 11, 2023 | marketbeat.comDnB Asset Management AS Takes $335,000 Position in IVERIC bio, Inc. (NASDAQ:ISEE)July 9, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Acquired by Hennion & Walsh Asset Management Inc.July 5, 2023 | marketbeat.comB.Riley Financial Sticks to Its Hold Rating for IVERIC bio (ISEE)June 30, 2023 | markets.businessinsider.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Acquired by Chartwell Investment Partners LLCJune 27, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Receives Average Rating of "Hold" from AnalystsJune 25, 2023 | marketbeat.comVoya Investment Management LLC Purchases 171,434 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)June 24, 2023 | marketbeat.comIVERIC bio (NASDAQ:ISEE) Now Covered by Analysts at StockNews.comJune 20, 2023 | marketbeat.comNeo Ivy Capital Management Purchases Shares of 17,910 IVERIC bio, Inc. (NASDAQ:ISEE)June 16, 2023 | marketbeat.comEversept Partners LP Purchases New Shares in IVERIC bio, Inc. (NASDAQ:ISEE)June 14, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by GSA Capital Partners LLPJune 9, 2023 | marketbeat.comAmerican International Group Inc. Buys 7,390 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)June 8, 2023 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)June 5, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by Moore Capital Management LPJune 2, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Average Rating of "Hold" by BrokeragesMay 31, 2023 | marketbeat.comIveric bio, Still A 5+% OpportunityMay 30, 2023 | seekingalpha.comAnnexon (ANNX) Stock Down More Than 50% Last Week: Here's WhyMay 30, 2023 | finance.yahoo.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by Artal Group S.A.May 29, 2023 | marketbeat.comBayer, Amgen looked at Iveric before agreeing to Astellas sale - reportMay 23, 2023 | seekingalpha.comCitigroup Inc. Reduces Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)May 22, 2023 | marketbeat.comTimesSquare Capital Management LLC Makes New Investment in IVERIC bio, Inc. (NASDAQ:ISEE)May 18, 2023 | marketbeat.comUnusual Call Option Trade in IVERIC bio (ISEE) Worth $1,780.50KMay 17, 2023 | msn.comArizona State Retirement System Boosts Stock Position in IVERIC bio, Inc. (NASDAQ:ISEE)May 17, 2023 | marketbeat.comQ2 2023 EPS Estimates for IVERIC bio, Inc. Reduced by Analyst (NASDAQ:ISEE)May 15, 2023 | marketbeat.comIVERIC Bio (NASDAQ: ISEE)May 10, 2023 | fool.comTD Cowen Downgrades IVERIC bio (ISEE)May 9, 2023 | msn.comSkandinaviska Enskilda Banken AB publ Reduces Stock Position in IVERIC bio, Inc. (NASDAQ:ISEE)May 8, 2023 | marketbeat.comSHAREHOLDER ALERT: Weiss Law Investigates IVERIC bio, Inc.May 2, 2023 | marketwatch.comMoore Kuehn Encourages ISEE, MDWT, CBOF, and SGEN Investors to Contact Law FirmMay 2, 2023 | benzinga.comSwiss National Bank Buys 82,000 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)May 2, 2023 | marketbeat.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IVERIC bio, Inc. BuyoutMay 1, 2023 | benzinga.comCheck Out What Whales Are Doing With ISEEMay 1, 2023 | benzinga.comAstellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'May 1, 2023 | finance.yahoo.comBiotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas PharmaMay 1, 2023 | finance.yahoo.comThese Stocks Are Moving the Most Today: First Republic, JPMorgan, Iveric Bio, SoFi, ON Semi, and MoreMay 1, 2023 | finance.yahoo.comFirst Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top StoriesMay 1, 2023 | finance.yahoo.comShareholder Alert: Ademi LLP investigates whether IVERIC bio, Inc. has obtained a Fair Price in its transaction with AstellasMay 1, 2023 | benzinga.comISEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Iveric bio, Inc. Is Fair to ShareholdersMay 1, 2023 | technews.tmcnet.comIveric Bio Shares Rise Premarket on Takeover by Astellas >ISEEMay 1, 2023 | marketwatch.comIveric Bio Stock Surges. It's Being Bought by Astellas for $5.9 Billion.May 1, 2023 | msn.com Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter. Email Address ISEE Media Mentions By Week ISEE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ISEE News Sentiment▼0.450.58▲Average Medical News Sentiment ISEE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ISEE Articles This Week▼00▲ISEE Articles Average Week Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHAXIAM Therapeutics News Today 60 Degrees Pharmaceuticals News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Lexaria Bioscience News Today Nutriband News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ISEE) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IVERIC bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IVERIC bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.